PACIRA BIOSCIENCES, INC. Restructuring Reserve
PACIRA BIOSCIENCES, INC. (PCRX) had Restructuring Reserve of $2.91 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Liabilities
us-gaap:RestructuringReserve · last filed 2024-05-07
- 2024-03-31: Restructuring Reserve $2.91M.
- 2023-12-31: Restructuring Reserve $0.00.
- 2020-12-31: Restructuring Reserve $19.00K.
- 2019-12-31: Restructuring Reserve $639.00K.
| Period end | Restructuring Reserve |
|---|---|
| 2024-03-31 | $2.91M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $0.00 10-Q · filed 2024-05-07 |
| 2020-12-31 | $19.00K 10-K · filed 2021-03-01 |
| 2019-12-31 | $639.00K 10-K · filed 2021-03-01 |
| 2018-12-31 | $2.25M 10-K · filed 2021-03-01 |
| 2017-12-31 | $2.08M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |